Elligo Health Research Announces New CEO

John Potthoff Transitions to Chairman, Barry Simms Promoted to CEO AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research®, the largest healthcare-enabling research organization, today announced that Elligo’s Founder and CEO, John Potthoff, Ph.D., transitioned his leadership to COO, Barry Simms. Potthoff will assume the role of Elligo’s Chairman, while Simms’ responsibilities will change to driving strategic direction as CEO — guiding the team and customers to make research as care … Continue reading Elligo Health Research Announces New CEO

Impact Newswire24/12/202324/12/2023

Global, United States

Pfizer Completes Acquisition of Seagen

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Seagen Inc. (NASDAQ: SGEN), a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. “Cancer remains a leading cause of death, and … Continue reading Pfizer Completes Acquisition of Seagen

Impact Newswire20/12/202320/12/2023

Global, United States

Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth

Kathy Spencer-Pike brings more than two decades of experience within highly matrixed Fortune 50 environments as well as fast-paced growth and start-up enterprises ROCHESTER, Minn.–(BUSINESS WIRE)–Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer. As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi … Continue reading Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth

Impact Newswire20/12/202320/12/2023

Europe, Global

AOP Health Receives Market Authorization for Landiolol in Canada

December 13, 2023 08:55 AM Eastern Standard Time VIENNA–(BUSINESS WIRE)–At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective β1-blocker Landiolol. The drug is used in intensive care to treat atrial fibrillation and atrial flutter (supraventricular tachycardia) and non-compensatory sinus tachycardia, hence when … Continue reading AOP Health Receives Market Authorization for Landiolol in Canada

Impact Newswire20/12/202320/12/2023

Global, United States

Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy

Mark Przekop brings over 35 years of radiopharmaceuticals commercialization and development experience from ARTMS and Jubilant Radiopharma December 07, 2023 07:15 AM Eastern Standard Time ROCHESTER, Minn.–(BUSINESS WIRE)–Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the expansion of its executive leadership team with Mark Przekop joining as Chief Operating Officer. As a veteran with over 35 … Continue reading Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy

Impact Newswire12/12/202312/12/2023

Europe, Global

Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

Velji brings more than 20 years of experience in biotech financial services December 06, 2023 08:00 AM Eastern Standard Time BASEL, Switzerland–(BUSINESS WIRE)–Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointed Chief Business Officer (CBO). He will lead corporate strategy, business development, and finance. Rizwan Velji, Chief Business Officer … Continue reading Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

Impact Newswire11/12/202311/12/2023

Europe, Global

EUROAPI Appoints New Executive Committee Members

November 28, 2023 02:00 AM Eastern Standard Time PARIS–(BUSINESS WIRE)–Regulatory News: EUROAPI (Paris:EAPI) today announced the appointment of David Seignolle as Chief Operating Officer, succeeding Eric Berger, and Marion Santin as Chief Legal, Compliance, and IP Officer, both joining the company’s Executive Committee. In his new role, David Seignolle will lead the transformation of the Industrial Operations organization, focusing on reinforcing robustness and compliance on … Continue reading EUROAPI Appoints New Executive Committee Members

Impact Newswire29/11/202329/11/2023

Global, Untied Kingdom

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

PUBLISHED – 20 November 2023 Evinova will operate as a separate health-tech business within AstraZeneca Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human experience-driven to serve clinical trial sponsors, clinical research organisations (CROs), clinical trial site care teams and patients First strategic collaborations with globally-leading CROs Parexel and Fortrea enable Evinova’s digital health solutions to be offered to their wide customer base AstraZeneca … Continue reading AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Impact Newswire22/11/202322/11/2023

Global, United States

Resilience Appoints Bill Marth as President of Services

November 07, 2023 08:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced that William S. Marth, RPh., MBA has been appointed to the newly created role of President of Services. “I am thrilled to join the esteemed executive team at Resilience, and I look forward to partnering with the team to … Continue reading Resilience Appoints Bill Marth as President of Services

Impact Newswire14/11/202314/11/2023